| Literature DB >> 19832037 |
Eiichi Nakai1, Kaechang Park, Toshio Yawata, Takahiro Chihara, Ayano Kumazawa, Hiromichi Nakabayashi, Keiji Shimizu.
Abstract
We established a cancer stem (CS) cell line, U87CS, by means of spheroid culture of U87MG cells derived from glioblastoma (GBM) in neuronal stem cell medium. U87CS cells presented positive immunohistochemical staining for multidrug resistance (MDR)1 and CD133, a marker for a subset of leukemia and GBM CS cells. The gene expression of MDR1 and CD133 on U87CS cells increased by an average of 8.51 and 47.18 times, respectively, compared to the levels on U87MG cells by real-time quantitative RT-PCR. U87CS cells possessed stronger drug-resistance to conventional anti-cancer drugs, such as doxorubicin (Dox), etoposide (VP-16), carboplastin, and BCNU than U87MG cells. Double immunofluoresence staining showed co-expression of MDR1 and CD133 on U87CS cells transplanted into nude mice brains. In addition, we identified the crossreactivity of CD133 and MDR1 in a surgical specimen of GBM. Our results suggest that CS cells may be resistant to current chemotherapy and represent a novel target for GBM therapeutics.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19832037 DOI： 10.3109/07357900801946679
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176